Your missing my point, we have been told SKTO owns and holds the intellectual rights to the processing techniques for extraction and production of Dharmanol and other BBio products. We were also told that SKTO aquired BBio, correct? Thus making this a no brainer that revenues would multiply quick like once products reached collectives and launch of sister site. SKTO was despribed as having several revenue sources Licensing, Branding, Consulting, Leasing Land, ETC. but with this newest developement those revenue streams will be leaving SKTO and would only leave the fee's associated with collectives thus lowering the overall market valuation of SKTO. With that I have concerns towards my ROI on the amount of time I've tied these funds up. Yet all is speculative until we hear from management. Don't you agree they should be compelled to update shareholders after a bomb like this is dropped. Hell down nearly 20% now!